Lifebank Corp.  

(Public, CVE:LBK)   Watch this stock  
Find more results for LBK
0.0000
- Close
CVE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 5.54M
P/E     -
Div/yield     -
EPS -0.01
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (May '12) 2012
Net profit margin 2.32% -1.72%
Operating margin 3.12% -2.27%
EBITD margin - 1.26%
Return on average assets 1.82% -1.37%
Return on average equity - -
Employees 22 -
CDP Score - -

Address

Technology Place - BCIT Campus Suite 200, 4475 Wayburne Drive
BURNABY, BC V5G 4X4
Canada
+1-604-7382722 (Phone)
+1-604-7382726 (Fax)

Website links

Description

Lifebank Corp. is engaged in the business of processing and cryopreserving umbilical cord blood stem cells for families. The Company provides three services related to umbilical cord blood stem cell banking: education and registration, processing (extracting the stem cells from the umbilical cord blood) and cryogenic (ultra-low temperature) storage. Expectant parents contact the Company to process and store their baby�s cord blood stem cells. The Company provides educational materials and answers to the questions and concerns on cord blood banking, using a no-pressure, informed consent model to assist in their decision to bank their baby�s cord blood. After the parents register, it provides them a collection kit and further educational materials, which are used by their delivering physician or mid-wife to collect the umbilical cord blood.